EUVIMEDEUVIMED entdecken
Crossref

Ruthenium(ii)–Arene Complex Triggers Immunogenic Ferroptosis for Reversing Drug Resistance

Mengdi Lv, Yue Zheng, Xiangyu Dai, Jingyue Zhao, Guojing Hu, Meng Ren, Zhengqi Shen, Zhi Su iD, Chao Wu, Hong-Ke Liu, Xuling Xue, Zong-Wan Mao iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Mengdi Lv und 11 weiteren Autor:innen. Beteiligte Einrichtung: National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal Un…. Hauptthemen laut MEDLINE: Ferroptosis, Drug Resistance, Neoplasm, Ruthenium, Antineoplastic Agents. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemoresistance remains an arduous challenge in oncology, but ferroptosis shows potential for overcoming it by stimulating the immune system. Herein, a novel high-performance ruthenium(II)-based arene complex [Ru(η6-p-cym)(BTBpy)Cl] (RuBTB) is developed for ferroptosis-enhanced antitumor immunity and drug resistance reversal via glutathione (GSH) metabolism imbalance. RuBTB shows significantly enhanced antiproliferation activity against cisplatin (CDDP)-resistant lung cancer cells (A549R), with 26.35-fold better anticancer effects than CDDP. Immunogenic ferroptosis is induced by GSH depletion/glutathione peroxidase 4 (GPX4) inactivation, mitochondrial dysfunction, and endoplasmic reticulum (ER) stress in RuBTB-treated cells. Mechanism studies indicate that RuBTB regulates ferroptosis and immune-related pathways, coordinating with GSH metabolism-mediated glutathione S-transferase (GST) inhibition to reverse drug resistance in platinum-combined therapy. Tumor vaccination experiments demonstrate the intensified antitumor effects endowed by highly immunogenic ferroptosis in vivo. This study provides the first example of a metal-arene complex for achieving satisfactory ferroptosis therapeutic effects with efficient immunogenicity to overcome drug resistance in metal-based immunochemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisDrug Resistance, NeoplasmRutheniumAntineoplastic AgentsHumansAnimalsMiceCoordination ComplexesCisplatinMice, Inbred BALB CGlutathioneCell ProliferationEndoplasmic Reticulum StressCell Line, Tumor

Substanzen

RutheniumAntineoplastic AgentsCoordination ComplexesCisplatinGlutathione

Autor:innen und Institutionen

  • National and Local Joint Engineering Research Center of Biomedical Functional Materials, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing 210023, PR China.
  • MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Development, IGCME, GBRCE for Functional Molecular Engineering, School of Chemistry, Sun Yat-Sen University, Guangz…
  • Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases; National Key Clinical Department and Key Discipline of Neurology; Department of Neurology, The First Affiliated Hospital, Su…

ORCID-Profile: Zhi Su, Zong-Wan Mao

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Lv, M., Zheng, Y., Dai, X., Zhao, J., Hu, G., Ren, M., Shen, Z., Su, Z., Wu, C., Liu, H. K., Xue, X., & Mao, Z. W. (2024). Ruthenium(ii)–Arene Complex Triggers Immunogenic Ferroptosis for Reversing Drug Resistance. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01467

Vancouver

Lv M, Zheng Y, Dai X, Zhao J, Hu G, Ren M, et al. Ruthenium(ii)–Arene Complex Triggers Immunogenic Ferroptosis for Reversing Drug Resistance. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01467

BibTeX
@article{Lv2024,
  author = {Lv, Mengdi and Zheng, Yue and Dai, Xiangyu and Zhao, Jingyue and Hu, Guojing and Ren, Meng and Shen, Zhengqi and Su, Zhi and Wu, Chao and Liu, Hong-Ke and Xue, Xuling and Mao, Zong-Wan},
  title = {Ruthenium(ii)–Arene Complex Triggers Immunogenic Ferroptosis for Reversing Drug Resistance},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01467}
}
Kostenlos starten →